CD200 is induced by ERK and is a potential therapeutic target in melanoma

Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to suffici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Petermann, Kimberly B., Rozenberg, Gabriela I., Zedek, Daniel, Groben, Pamela, McKinnon, Karen, Buehler, Christin, Kim, William Y., Shields, Janiel M., Penland, Shannon, Bear, James E., Thomas, Nancy E., Serody, Jonathan S., Sharpless, Norman E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2007
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075477/
https://ncbi.nlm.nih.gov/pubmed/18008004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados